The limited precision of phase I trials.
M C
MC
Christian
E L
EL
Korn
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic / Q000592:standards*; D015986:Confounding Factors, Epidemiologic; D006801:Humans; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy*; D014481:United States
D000970:Antineoplastic Agents